Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLoose skin after significant weight loss is a real concern, and if you're researching Mounjaro it's one of the first questions worth getting a straight answer on. The honest position: losing a large amount of weight, through any means, can leave skin that doesn't fully spring back, and Mounjaro is no exception. What the evidence suggests, though, is that the rate of loss and a handful of practical factors can make a meaningful difference to how much loose skin develops. These are prescription-only medicines requiring a clinical assessment before they're prescribed; a prescriber decides whether treatment is appropriate for you and can talk through realistic expectations, including skin changes.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The question of loose skin gets attached to Mounjaro by name, but the mechanism isn't the medicine itself. Skin loses elasticity when the fat beneath it reduces faster than the skin can contract. That process would happen with any sustained calorie deficit that produces the same degree of loss. What's worth understanding is that Mounjaro produces, on average, considerably more total weight loss than most people achieve through lifestyle changes alone, published trial data for tirzepatide show average reductions of around 20% of body weight over 72 weeks at the highest dose. A larger total loss naturally raises the question of how skin responds. But the comparison isn't Mounjaro versus doing nothing; it's Mounjaro versus other routes to the same outcome, and on that basis the picture is more nuanced.
Tirzepatide is titrated slowly, starting at 2.5mg and increasing in steps over several months under prescriber oversight. That pace tends to produce a more gradual trajectory of fat loss than very-low-calorie crash approaches. Slower loss gives the skin's collagen and elastin structures more time to remodel. No medicine can guarantee skin tightening, but the dose schedule isn't the enemy here. Genetic factors, starting weight, age and how long excess weight has been carried all matter more than the specific drug.
If you want a detailed breakdown of how this question is framed clinically, the page on whether Mounjaro causes loose skin covers the biology in more depth.
Several factors influence how skin responds to fat loss, and most clinicians would name the same shortlist. Age is probably the biggest: skin in your twenties has considerably more elasticity than skin in your fifties, simply because collagen production slows as we age. Starting weight matters too, someone losing 20kg from a BMI of 33 is starting from a different point than someone losing 40kg from a BMI of 48, and the latter group generally has more redundant skin to begin with.
Muscle mass is a less obvious but practically important factor. Skin supported by developed muscle tissue sits differently from skin over an area where both fat and muscle have reduced. This is why resistance training gets mentioned so often alongside GLP-1 treatment: it's not purely about aesthetics during the process; it affects the end result. Protein intake sits alongside this, adequate protein is needed for muscle retention when the body is in a caloric deficit, and many people on Mounjaro find their appetite reduced to the point where hitting protein targets takes deliberate planning.
Hydration, sun exposure history and smoking history also affect skin elasticity, though these are background factors rather than levers you can pull overnight. The practical strategies for minimising loose skin on Mounjaro covers the modifiable ones in detail, including what the evidence actually says about topical creams (it's limited).
If you're mid-treatment and starting to notice skin changes, the first thing worth saying is that skin continues to contract for a significant period after weight stabilises, often 12 to 24 months. Many people who are concerned at 6 months are meaningfully less so at 18 months, once their weight has settled and the skin has had time to catch up. Rushing to conclusions during active loss tends to cause unnecessary worry.
Practically, the things most likely to help are consistent resistance training (even two sessions a week makes a difference over time), adequate protein, and staying well hydrated. These aren't glamorous answers, but they're the ones with the best evidence behind them. If you're asking whether you'll get loose skin with Mounjaro, the honest answer depends heavily on your individual starting point and how your body responds over time. Surgical skin removal is an option for cases where loose skin is substantial and causing physical or psychological difficulty, but it's a separate conversation for after treatment has finished and weight has been stable for a period, a GP or specialist can advise on whether that route is appropriate.
The wider question of how Mounjaro affects your skin more broadly, beyond loose skin specifically, is covered on the Mounjaro and skin changes page. And if you're earlier in your research (weighing up whether this is the right treatment path at all) the weight-loss treatment overview sets out what's available and what the differences are.
Loose skin is a legitimate concern and worth raising directly with a prescriber. It doesn't disqualify anyone from treatment, but it is the kind of thing that deserves an honest conversation rather than a quick reassurance. At nume, consultations are reviewed the same day by a GPhC-registered prescriber, a real clinician reads your answers, not a script. If you're thinking about starting treatment, starting with a free consultation is the sensible first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.